Tag: Medicare Part B reimbursement
Biosimilars are billed differently than generics under Medicare Part B. Each has its own HCPCS code and payment rate based on its ASP plus 6% of the reference product’s price. This system encourages biosimilar entry but doesn’t strongly incentivize switching. Learn how billing works and why adoption remains low in the U.S.
Medications
Archives
Recent-posts
Noni: Unlocking Polynesian Secrets for Health and Wellness
May, 9 2024
Counterfeit Medication Red Flags: What to Watch For
Dec, 1 2025
Switching Health Plans: How to Evaluate Generic Drug Coverage and Save Money
Jun, 8 2026
How Salt Triggers Edema: Exploring Kidney Sodium Balance & Fluid Retention
Jul, 14 2025
The Future of Bladder Infection Treatments: New Research and Innovations
Sep, 24 2025